Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1 Free

Abstract

Human immunodeficiency virus type 1 (HIV-1) Gag-specific cytotoxic T lymphocyte (CTL) responses were studied in seven seropositive long-term asymptomatic individuals (CDC A1) with stable CD4 counts for more than 8 years. Using a set of partially overlapping peptides covering the whole Gag, five 15–20-mer peptides were found to contain CTL epitopes. Further characterization of these epitopes revealed a new HLA-A25-restricted CTL epitope in p24, p24 ETINEEAAEW. This region of Gag is highly conserved in clades B and D of HIV-1. Naturally occurring amino acid sequences, containing p24D (consensus HIV-1 clades A, C, F, G and H) or p24I (HIV-2) were not recognized by CTL recognizing the index peptide. No virus variants with mutations in this sequence were found in peripheral blood mononuclear cells from the HIV-1-infected individual concerned during the 8 year observation period, indicating that the virus had not escaped from the observed CTL response.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-8-1659
1996-08-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/8/JV0770081659.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-8-1659&mimeType=html&fmt=ahah

References

  1. Buseyne F., McChesney M., Porrot F., Kovarik S., Guy B., Riviere Y. 1993; Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein. Journal of Virology 67:694–702
    [Google Scholar]
  2. Centers for Disease Control 1992; 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report 41:1–19
    [Google Scholar]
  3. Cheynier R., Langlade-Demoyen P., Marescot M. R., Blanche S., Blondin G., Wain-Hobson S., Griscelli C., Vilmer E., Plata F. 1992; Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. European Journal of Immunology 22:2211–2217
    [Google Scholar]
  4. de Wolf F., Goudsmit J., Paul D. A., Lange J. M., Hooijkaas C., Schellekens P., Coutinho R. A., van der Noordaa J. 1987; Risk of AIDS related complex and AIDS in homosexual men with persistant HIV antigenaemia. British Medical Journal 295:569–572
    [Google Scholar]
  5. Heeney J. L., van Els C., de Vries P., ten Haaft P., Otting N., Koornstra W., Boes J., Dubbes R., Niphuis H., Dings M., Cranage M., Norley S., Jonker M., Bontrop R. E., Osterhaus A. 1994; Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. Journal of Experimental Medicine 180:769–774
    [Google Scholar]
  6. Jassoy C., Johnson R. P., Navia B. A., Worth J., Walker B. D. 1992; Detection of a vigorous HIV-l-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. Journal of Immunology 149:3113–3119
    [Google Scholar]
  7. Johnson R. P., Walker B. D. 1994; Cytotoxic T lymphocytes in human immunodeficiency virus infection: responses to structural protein. Current Topics in Microbiology and Immunology 189:35–63
    [Google Scholar]
  8. Johnson R. P., Trocha A., Yang L., Mazzara G. P., Panicali D. L., Buchanan M. T., Walker B. D. 1991; HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. Journal of Immunology 147:1512–1521
    [Google Scholar]
  9. Keet I. P., Krol A., Klein M. R., Veugelers P., de Wit J., Roos M., Koot M., Goudsmit J., Miedema F., Coutinho R. A. 1994; Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4 + cell counts. Journal of Infectious Diseases 169:1236–1243
    [Google Scholar]
  10. Klein M. R., van Baalen C. A., Holwerda A. M., Kerkhof Garde S. R., Bende R. J., Keet I. P. M., Eeftinck-Schattenker J. M., Osterhaus A. D. M. E., Miedema F. 1995; Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: Different for rapid progressors and long-term asymptomatics. Journal of Experimental Medicine 181:1365–1372
    [Google Scholar]
  11. Koup R. A., Safrit J. T., Cao Y., Andrews C. A., McLeod G., Borkowsky W., Farthing C., Ho D. D. 1994; Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 68:4650–4655
    [Google Scholar]
  12. Myers G., Wain-Hobson S., Henderson L. E., Korber B., Jeang K., Pavlakis G. N. 1994 Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic and Amino Acid Sequences Los Alamos, N. Mex.; Los Alamos National Laboratory.:
    [Google Scholar]
  13. Nixon D. F., Townsend A. R., Elvin J. G., Rizza C. R., Gallwey J., McMichael A. J. 1988; HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484–487
    [Google Scholar]
  14. Rautmann G., Kieny M. P., Brandely R., Dott K., Girard M., Montagnier L., Lecocq J. P. 1989; HIV-1 core proteins expressed from recombinant vaccinia viruses. AIDS Research and Human Retroviruses 5:147–157
    [Google Scholar]
  15. Riviere Y., Robertson M. N., Buseyne F. 1994; Cytotoxic T lymphocytes in human immunodeficiency virus infection: regulator genes. Current Topics in Microbiology and Immunology 189:65–74
    [Google Scholar]
  16. Rowland-Jones S. L., Nixon D. F., Aldhous M. C., Gotch F., Ariyoshi K., Hallam N., Kroll J. S., Froebel K., McMichael A. 1993; HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 341:860–861
    [Google Scholar]
  17. Rowland-Jones S., Sutton J., Ariyoshi K., Dong T., Gotch F., McAdam S., Whitby D., Sabally S., Gallimore A., Corrah T., Takiguchi M., Shultz T., McMichael A., Whittle H. 1995; HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Medicine 1:59–64
    [Google Scholar]
  18. Schuitemaker H., Koot M., Kootstra N. A., Dercksen M. W., de Goede R. E., van Steenwijk R. P., Lange J. M., Schattenkerk J. K., Miedema F., Tersmette M. 1992; Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. Journal of Virology 66:1354–1360
    [Google Scholar]
  19. van Baalen C. A., Klein M. R., Geretti A. M., Keet R. I., Miedema F., van Els C. A., Osterhaus A. D. M. E. 1993; Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8 + T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS 7:781–786
    [Google Scholar]
  20. van de Griend R. J., van Krimpen B. A., Bol S. J., Thompson A., Bolhuis R. L. 1984; Rapid expansion of human cytotoxic T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cells. Journal of Immunological Methods 66:285–298
    [Google Scholar]
  21. van der Burg S. H., Klein M. R., van de Velde C. J. H., Kast M., Miedema F., Meiief C. J. M. 1995; Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase. AIDS 9:121–127
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-8-1659
Loading
/content/journal/jgv/10.1099/0022-1317-77-8-1659
Loading

Data & Media loading...

Most cited Most Cited RSS feed